<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-05T20:28:50+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>价格和招采信用评价全面落地，合规面临更大挑战。</title>
    <updated>2021-01-05T17:46:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/n2eaZJ5riPIi_6AKyZq38g</id>
    <link href="https://mp.weixin.qq.com/s/n2eaZJ5riPIi_6AKyZq38g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采新格局，氨溴索11家，帕瑞昔布8家，3进2仅剩19个！</title>
    <updated>2021-01-01T10:43:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/zW17KAl3qg21MN1heXwqQA</id>
    <link href="https://mp.weixin.qq.com/s/zW17KAl3qg21MN1heXwqQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>寄语2021| 不畏过往 奋勇前行  风云药谈祝大家元旦快乐！</title>
    <updated>2020-12-31T23:19:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/yF6vrod6jrBp_PiCGrxX-w</id>
    <link href="https://mp.weixin.qq.com/s/yF6vrod6jrBp_PiCGrxX-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅：2020版短缺药发布（附厂家清单），又要火了！</title>
    <updated>2020-12-30T18:59:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/cxELQ-WEqGrF_my_BL9Mmw</id>
    <link href="https://mp.weixin.qq.com/s/cxELQ-WEqGrF_my_BL9Mmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020版医保进出产品、降幅、价格明细，深度解析！</title>
    <updated>2020-12-29T09:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/4fvqJvQ6BrxHQg4LPPkung</id>
    <link href="https://mp.weixin.qq.com/s/4fvqJvQ6BrxHQg4LPPkung" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浙江“小单元竞价”开始，艾司奥美拉唑注射剂遭暴击！</title>
    <updated>2020-12-29T09:22:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/f7V2pt2KX9XqsV75s9cyhg</id>
    <link href="https://mp.weixin.qq.com/s/f7V2pt2KX9XqsV75s9cyhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅：2020版医保目录公布，119个新增，29个调出，平均降幅50.64%！</title>
    <updated>2020-12-28T10:20:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/kJR2HSC3B078y4HgaRH6yg</id>
    <link href="https://mp.weixin.qq.com/s/kJR2HSC3B078y4HgaRH6yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采最新竞争格局（12.27），氨溴索废了！</title>
    <updated>2020-12-27T14:56:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/iN3BVAQnWElBpDHtjktbKQ</id>
    <link href="https://mp.weixin.qq.com/s/iN3BVAQnWElBpDHtjktbKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年地方带量采汇总，收藏！</title>
    <updated>2020-12-26T14:24:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/_lTjatVn_HjsEH1nKKkpaQ</id>
    <link href="https://mp.weixin.qq.com/s/_lTjatVn_HjsEH1nKKkpaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人最值得关注的8个公众号！</title>
    <updated>2020-12-26T14:24:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/TeSSblv_GM_qkDDtILDavg</id>
    <link href="https://mp.weixin.qq.com/s/TeSSblv_GM_qkDDtILDavg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅来袭：六十亿头孢呋辛注射剂首家过评！</title>
    <updated>2020-12-25T15:08:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/E0J2rEUemFJeD0zidK63Cg</id>
    <link href="https://mp.weixin.qq.com/s/E0J2rEUemFJeD0zidK63Cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人最值得关注的8个公众号！</title>
    <updated>2020-12-24T13:47:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/ytBIWxJHjgZ1GAJIUqsomA</id>
    <link href="https://mp.weixin.qq.com/s/ytBIWxJHjgZ1GAJIUqsomA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>